Su M. Phyu

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Exosomal survivin as a liquid biopsy biomarker in cancer.

Exosomal survivin as a liquid biopsy biomarker in cancer.

Journal: Journal of immunological methods

Published: February 18, 2026

TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity.

TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

The vital role of p97/valosin-containing protein-mediated degradation pathways in tumour immunity.

The vital role of p97/valosin-containing protein-mediated degradation pathways in tumour immunity.

Journal: Current opinion in cell biology

Published: October 14, 2025

Interactions between cancer-associated fibroblasts and the extracellular matrix in oesophageal cancer.

Interactions between cancer-associated fibroblasts and the extracellular matrix in oesophageal cancer.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: April 07, 2025

IGF-1 regulates cancer cell immune evasion in prostate cancer.

IGF-1 regulates cancer cell immune evasion in prostate cancer.

Journal: Scientific reports

Published: March 15, 2025

Extracellular Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A Review.

Extracellular Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A Review.

Journal: Frontiers in bioscience (Landmark edition)

Published: April 10, 2024

Non-cell-autonomous cancer progression from chromosomal instability.

Non-cell-autonomous cancer progression from chromosomal instability.

Journal: Nature

Published: December 09, 2021

The clinical and molecular significance associated with STING signaling in breast cancer.

The clinical and molecular significance associated with STING signaling in breast cancer.

Journal: NPJ breast cancer

Published: October 07, 2020

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Journal: British journal of cancer

Published: March 28, 2020

CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.

CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.

Journal: Magma (New York, N.Y.)

Published: August 20, 2018

Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation.

Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation.

Journal: Investigational new drugs

Published: June 15, 2018

Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism.

Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism.

Journal: BioMed research international

Published: March 22, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026